The standard case for the fund is to invest in rounds with 8 partakers. Despite the Polaris Founders Capital, startups are often financed by U.S. Department of Defense, Taiwania Capital, Korea Investment Partners. The meaningful sponsors for the fund in investment in the same round are Taiwania Capital, RTW Investments LLC, Perceptive Advisors.
The high activity for fund was in 2019. The increased amount of exits for fund were in 2019. The fund is generally included in less than 2 deals every year. Deals in the range of 50 - 100 millions dollars are the general things for fund.
Among the most popular portfolio startups of the fund, we may highlight Frequency Therapeutics. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical, Biotechnology.
We also calculated 2 valuable employees in our database.
Related Funds
Fund Name | Location |
Batlivala & Karani Securities | India, Maharashtra, Mumbai |
BIA Digital Partners | Chantilly, United States, Virginia |
Blue Ventures | England, London, United Kingdom |
Cadron Creek Capital | Arkansas, Conway, United States |
Growth Cash | - |
gumi | Japan, Tokyo |
Hundreds Capital | Beijing, Beijing, China |
iBuy | Australia, Melbourne, Victoria |
Investissements W2 | - |
Pearson | England, London, United Kingdom |
Rongta Touzi | Beijing, Beijing, China |
Shengtong Printing | Beijing, Beijing, China |
Silver Tiger Capital | Beijing, Beijing, China |
Teng Yue Partners | New York, New York, United States |
The Low Carbon Enterprise Fund | - |
Third Coast Capital Advisors | Chicago, Illinois, United States |
Wuhan Haizhida Keji Touzi Youxian Gongsi | China, Hubei, Wuhan |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Amylyx Pharmaceuticals | $135M | 20 Jul 2021 | Cambridge, Massachusetts, United States | ||
Akouos | $105M | 03 Mar 2020 | Boston, Massachusetts, United States | ||
Frequency Therapeutics | $62M | 23 Jul 2019 | Woburn, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Amylyx Pharmaceuticals | $135M | 20 Jul 2021 | Cambridge, Massachusetts, United States | ||
Akouos | $105M | 03 Mar 2020 | Boston, Massachusetts, United States | ||
Frequency Therapeutics | $62M | 23 Jul 2019 | Woburn, Massachusetts, United States |